Annual report pursuant to Section 13 and 15(d)

Fair Value Hierarchy (Details)

Fair Value Hierarchy (Details) (USD $)	12 Months Ended
Fair Value Hierarchy (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Sep. 30, 2013
Fair Value Measurements [Line Items]
Change in fair value of financial instruments	$ (1,342,389)	$ (112,073)	$ 32,110
Derivative liabilities	0us-gaap_DerivativeLiabilities	7,692,087us-gaap_DerivativeLiabilities
Fair Value, Measurements, Recurring [Member]
Fair Value Measurements [Line Items]
Platinum notes payable	5,615,764	4,268,062
Derivative liabilities		7,692,087
Fair Value, Measurements, Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Fair Value Measurements [Line Items]
Derivative liabilities		7,692,087		7,700,000
Fair Value, Measurements, Recurring [Member] \| Significant Unobservable Inputs (Level 3) [Member]
Fair Value Measurements [Line Items]
Platinum notes payable	5,615,764	4,268,062
Platinum Montaur Life Sciences Llc Credit Facility [Member]
Fair Value Measurements [Line Items]
Change in fair value of financial instruments		106,000
Platinum notes payable	5,600,000
Platinum Montaur Life Sciences Llc Credit Facility [Member] \| Significant Unobservable Inputs (Level 3) [Member]
Fair Value Measurements [Line Items]
Change in fair value of financial instruments	$ 1,348,000

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.

+ References + Details